Literature DB >> 24887732

Lower vitamin D levels in surgical hyperparathyroidism versus thyroid patients.

Brenessa M Lindeman1, Catherine E Pesce, Hua-Ling Tsai, Helina Somervell, Christopher B Umbricht, Jeanne Kowalski, Martha A Zeiger.   

Abstract

Low vitamin D levels have been shown to be associated with primary hyperparathyroidism, but it is unclear whether vitamin D deficiency may be an etiologic factor in the development of primary hyperparathyroidism. To investigate this, we compared preoperative vitamin D levels of patients undergoing surgery for primary hyperparathyroidism with those of patients undergoing surgery for benign thyroid disease. With Institutional Review Board approval, data were collected prospectively on patients undergoing parathyroidectomy or thyroidectomy by one surgeon between March 2006 and July 2011. Patients were excluded if they underwent simultaneous thyroid and parathyroid surgery, had secondary or tertiary hyperparathyroidism, if no preoperative vitamin D level was measured, or if they took vitamin D supplements. Inclusion criteria were met by 219 patients who underwent parathyroidectomy and 186 patients who underwent thyroid surgery. Patient age, sex, race, and preoperative vitamin D levels (vitamin D 25-OH; normal, 32 to 100 pg/mL) were collected. Statistical analysis was performed using linear regression. Vitamin D levels were significantly lower in the parathyroid group compared with the thyroid group (23.8 vs 28.5 pg/mL; P < 0.001). This difference was also observed after adjustment for age, sex, and race with a mean difference of 4.87 pg/mL (P < 0.001). Statistically significant associations between lower vitamin D levels and patients younger than 50 years (P = 0.048), male sex (P = 0.03), and nonwhite race were identified (P < 0.001). Patients with primary hyperparathyroidism are more likely to have lower vitamin D levels than a control surgical population. Further study is needed to determine whether low vitamin D levels may be an etiologic factor associated with the development of hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24887732      PMCID: PMC4362715     

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  19 in total

Review 1.  Surgical treatment of primary hyperparathyroidism.

Authors:  Mathew M Augustine; Paco E Bravo; Martha A Zeiger
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

2.  The effects of vitamin D insufficiency in patients with primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; D W Dempster; J P Bilezikian
Journal:  Am J Med       Date:  1999-12       Impact factor: 4.965

3.  Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.

Authors:  T Carling; J Rastad; E Szabó; G Westin; G Akerström
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

4.  Risk factors for severe postoperative hypocalcaemia after operations for primary hyperparathyroidism.

Authors:  Bengt Ahringberg Kald; Charlotte L Mollerup
Journal:  Eur J Surg       Date:  2002

5.  Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications.

Authors:  D S Rao; M Honasoge; G W Divine; E R Phillips; M W Lee; M R Ansari; G B Talpos; A M Parfitt
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism.

Authors:  V Kantorovich; M A Gacad; L L Seeger; J S Adams
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

Review 7.  Vitamin D and the parathyroid.

Authors:  P Beckerman; J Silver
Journal:  Am J Med Sci       Date:  1999-06       Impact factor: 2.378

8.  25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.

Authors:  Ulrika Segersten; Pamela Correa; Martin Hewison; Per Hellman; Henning Dralle; Tobias Carling; Göran Akerström; Gunnar Westin
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

9.  Are preoperative serum calcium, parathyroid hormone, and adenoma weight predictive of postoperative hypocalcemia?

Authors:  Pamela L Strickland; James Recabaren
Journal:  Am Surg       Date:  2002-12       Impact factor: 0.688

10.  Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.

Authors:  Elizabeth A Mittendorf; James I Merlino; Christopher R McHenry
Journal:  Am Surg       Date:  2004-02       Impact factor: 0.688

View more
  1 in total

1.  Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry.

Authors:  Maria D Jackson; Marshall K Tulloch-Reid; Carole M Lindsay; Garrett Smith; Franklyn I Bennett; Norma McFarlane-Anderson; William Aiken; Kathleen C M Coard
Journal:  Cancer Med       Date:  2015-04-07       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.